Figure 2.
Comparison of metabolic profiles of different tea accessions. (A) Principal component analysis of different tea accessions based on the content of metabolites. (B) Volcano plot of differentially accumulated metabolites (DAMs) between Group 1 and Group 2. (C) Volcano plot of DAMs between Group 1 and Group 3. (D) Volcano plot of DAMs between Group 2 and Group 3. aa-001, L-Arginine; aa-010, L-Theanine; aa-017, Nicotinamide; aa-026, Gallocatechin; aa-027, Neochlorogenic acid; aa-028, Theobromine; aa-031, 3,4-Dihydroxybenzaldehyde; aa-033, Procyanidin B3; aa-034, Catechin; aa-039, 4-Hydroxybenzaldehyde; aa-040, Caffeine; aa-063, Procyanidin B1; aa-066, Vitexin-2”-O-rhamnoside; aa-070, Quercitrin; aa082, 1,2-di-O-galloyl-hhdp-glucose; aa-084, GC-GCG; bb-011, diGC-GA; cc-001, Agmatine; cc-005, 4-Amino-4-deoxypentopyranose; cc-015, 2-Acetamido-2-deoxyglucose; cc-025, 4-piperidinecarboxamide; cc-026, Ethanal tetramer; aa-052, Quercetin 3-O-alpha-D-xylopyranoside; cc-008, (2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid; cc-047, N-phenyl-beta-D-glucopyranosylamine; cc-050, Tert-butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate; cc-085, Benzyl 6-O-beta-D-xylopyranosyl-beta-d-glucopyranoside; cc-099, 4,7,8-trihydroxy-3-(4-hydroxyphenyl)dibenzo[b,d]furan-1,2-diyl diacetate ; cc-114, Gallocatechin-(4alpha->8)-epigallocatechin; cc-142, 1,4-anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol; cc-029, 5'-Xanthylic acid; cc-032, Streptamine 4-phosphate; cc-037, Gly-lys; cc-041, 2-Methylcitric acid; cc-044, Hymexazol O-glucoside; cc-048, N-acetyl-l-2-aminoadipic acid; cc-068, Nifurquinazol; cc-082, Aspirin; cc-084, 1-O-vanilloyl-beta-D-glucose; cc-106, Mascaroside; cc-111, Astilbin; cc-117, Tiliroside; cc-118, Olsalazine; cc-120, Cynarine; cc-130, Silandrin; cc-132, Kolaflavanone; cc-134, Lamifiban; cc-137, Methyl 3,4,5-trimethoxycinnamate; cc-139, Propofol; cc-140, 7-Dehydrocholesterol benzoate; cc-153, Beta-D-ethyl glucuronide.
